Literature DB >> 19931595

Mitochondrial mechanisms of estrogen neuroprotection.

James W Simpkins1, Kun Don Yi, Shao-Hua Yang, James A Dykens.   

Abstract

Mitochondria have become a primary focus in our search not only for the mechanism(s) of neuronal death but also for neuroprotective drugs and therapies that can delay or prevent Alzheimer's disease and other chronic neurodegenerative conditions. This is because mitochrondria play a central role in regulating viability and death of neurons, and mitochondrial dysfunction has been shown to contribute to neuronal death seen in neurodegenerative diseases. In this article, we review the evidence for the role of mitochondria in cell death and neurodegeneration and provide evidence that estrogens have multiple effects on mitochondria that enhance or preserve mitochondrial function during pathologic circumstances such as excitotoxicity, oxidative stress, and others. As such, estrogens and novel non-hormonal analogs have come to figure prominently in our efforts to protect neurons against both acute brain injury and chronic neurodegeneration.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931595      PMCID: PMC2889195          DOI: 10.1016/j.bbagen.2009.11.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  195 in total

1.  Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex.

Authors:  M Singh
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

2.  Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD.

Authors:  D A Cottrell; E L Blakely; M A Johnson; P G Ince; D M Turnbull
Journal:  Neurology       Date:  2001-07-24       Impact factor: 9.910

Review 3.  The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease.

Authors:  J W Simpkins; M Singh; J Bishop
Journal:  Neurobiol Aging       Date:  1994       Impact factor: 4.673

4.  Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription.

Authors:  S M Aronica; W L Kraus; B S Katzenellenbogen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

5.  Absolute kinetic characterization of 17-beta-estradiol as a radical-scavenging, antioxidant synergist.

Authors:  J S Winterle; T Mill; T Harris; R A Goldbeck
Journal:  Arch Biochem Biophys       Date:  2001-08-15       Impact factor: 4.013

6.  Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated CA2+ and Na+: implications for neurodegeneration.

Authors:  J A Dykens
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

7.  Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro.

Authors:  J Bishop; J W Simpkins
Journal:  Mol Cell Neurosci       Date:  1994-08       Impact factor: 4.314

8.  Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.

Authors:  V W Henderson; A Paganini-Hill; C K Emanuel; M E Dunn; J G Buckwalter
Journal:  Arch Neurol       Date:  1994-09

9.  Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes.

Authors:  M B Ruiz-Larrea; A M Leal; M Liza; M Lacort; H de Groot
Journal:  Steroids       Date:  1994-06       Impact factor: 2.668

10.  In vitro modulation of antioxidant enzyme levels in normal hamster kidney and estrogen-induced hamster kidney tumor.

Authors:  T D Oberley; J L Schultz; L W Oberley
Journal:  Free Radic Biol Med       Date:  1994-06       Impact factor: 7.376

View more
  69 in total

Review 1.  Estrogen neuroprotection and the critical period hypothesis.

Authors:  Erin Scott; Quan-guang Zhang; Ruimin Wang; Ratna Vadlamudi; Darrell Brann
Journal:  Front Neuroendocrinol       Date:  2011-11-04       Impact factor: 8.606

Review 2.  Nonhuman primate models of Alzheimer-like cerebral proteopathy.

Authors:  Eric Heuer; Rebecca F Rosen; Amarallys Cintron; Lary C Walker
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 3.  Estrogens regulate life and death in mitochondria.

Authors:  Carolyn M Klinge
Journal:  J Bioenerg Biomembr       Date:  2017-08       Impact factor: 2.945

Review 4.  Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Authors:  Lucio G Costa; Rian de Laat; Khoi Dao; Claudia Pellacani; Toby B Cole; Clement E Furlong
Journal:  Neurotoxicology       Date:  2013-09-04       Impact factor: 4.294

5.  17β-estradiol confers protection after traumatic brain injury in the rat and involves activation of G protein-coupled estrogen receptor 1.

Authors:  Nicole L Day; Candace L Floyd; Tracy L D'Alessandro; William J Hubbard; Irshad H Chaudry
Journal:  J Neurotrauma       Date:  2013-07-23       Impact factor: 5.269

Review 6.  Estrogen signaling and cardiovascular disease.

Authors:  Elizabeth Murphy
Journal:  Circ Res       Date:  2011-09-02       Impact factor: 17.367

Review 7.  Perimenopause as a neurological transition state.

Authors:  Roberta D Brinton; Jia Yao; Fei Yin; Wendy J Mack; Enrique Cadenas
Journal:  Nat Rev Endocrinol       Date:  2015-05-26       Impact factor: 43.330

8.  Estrogen receptor beta modulates permeability transition in brain mitochondria.

Authors:  Suzanne R Burstein; Hyun Jeong Kim; Jasmine A Fels; Liping Qian; Sheng Zhang; Ping Zhou; Anatoly A Starkov; Costantino Iadecola; Giovanni Manfredi
Journal:  Biochim Biophys Acta Bioenerg       Date:  2018-03-14       Impact factor: 3.991

9.  Rapid mitochondrial dysfunction mediates TNF-alpha-induced neurotoxicity.

Authors:  Danielle N Doll; Stephanie L Rellick; Taura L Barr; Xuefang Ren; James W Simpkins
Journal:  J Neurochem       Date:  2015-01-29       Impact factor: 5.372

Review 10.  Therapeutic strategies in Friedreich's ataxia.

Authors:  Timothy E Richardson; Heather N Kelly; Amanda E Yu; James W Simpkins
Journal:  Brain Res       Date:  2013-04-13       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.